FLUAD

STN: 125510 
Proper Name: Influenza Vaccine, Adjuvanted
Tradename: FLUAD
Manufacturer: Seqirus, Inc.

Indication

• For active immunization of persons 65 years of age and older against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.

Product Information

• Package Insert - FLUAD

Supporting Documents

• July 1, 2026 Approval Letter - FLUAD
• July 1, 2025 Approval Letter - FLUAD
• July 1, 2024 Approval Letter - FLUAD
• July 2, 2021 Approval Letter - FLUAD
• Statistical Review - FLUAD and FLUAD Quadrivalent
• Clinical Review - FLUAD and FLUAD Quadrivalent
• October 28, 2020 Approval Letter - Fluad and Fluad Quadrivalent
• July 2, 2020 Approval Letter Fluad and Fluad Quadrivalent
• May 13, 2020 Approval Letter - FLUAD
• July 2, 2019 Approval Letter - Fluad
• April 18, 2019 Approval Letter - FLUAD
• July 13, 2018 Approval Letter - Fluad
• July 7, 2017 Approval Letter - Fluad
• Approval History, Letters, Reviews, and Related Documents - FLUAD
• Supporting Documents older than three years - FLUAD